Filing Details

Accession Number:
0001140361-11-011700
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-23 20:02:04
Reporting Period:
2011-02-18
Filing Date:
2011-02-23
Accepted Time:
2011-02-23 20:02:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL Services-Commercial Physical & Biological Research (8731) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360545 Harvey Lalach 4837 Canyon Ridge Crescent
Kelowna A1 V1W 4A1
President Coo Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-18 3,000 $3.75 597,000 No 4 S Direct
Common Stock Disposition 2011-02-18 1,628 $3.74 595,372 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 600,000 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock stock options $3.10 2008-06-03 2013-06-03 150,000 150,000 Direct
Common Stock stock options $3.50 2010-06-29 2015-06-29 50,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2013-06-03 150,000 150,000 Direct
2015-06-29 50,000 200,000 Direct